Milestone Pharmaceuticals

/Milestone Pharmaceuticals

We are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.

Symbol

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Effective Date
May 9, 2019

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange